Sipuleucel-T With or Without Radiation Therapy in Treating Patients With Hormone-Resistant Metastatic Prostate Cancer | MicrobiomeTrials← Back to trialsNCT01807065
Sipuleucel-T With or Without Radiation Therapy in Treating Patients With Hormone-Resistant Metastatic Prostate Cancer
CompletedPHASE2INTERVENTIONAL
Trial Details
Start: 2013-06-25Est. Completion: 2018-12-31
Enrollment target: 51 participants Locations- City of Hope Medical Center, Duarte, California, United States
- South Pasadena Cancer Center, Pasadena, California, United States
- Huntsman Cancer Institute, Univ. of Utah, Salt Lake City, Utah, United States
Other microbiome trials you might be interested in
Cancer
TTX-080-001 is a Phase 1, open label, dose escalation and dose expansion clinical study to determine the safety, tolerab…
Tucson, United StatesEst. completion Jun 1, 2027
Metastatic Castration-Resistant Prostate Cancer (mCRPC)Clear Cell Renal Cell Carcinoma (ccRCC)
This study is researching a new drug called REGN15505 when used alone or in combination with cemiplimab or in combinatio…
Goodyear, United StatesEst. completion Oct 27, 2030